Study of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic Syndromes
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is an interventional, multicenter, open label, phase II study designed to evaluate the
safety and efficacy of Clofarabine in combination with low dose Cytarabine in untreated
patients with poor risk of Myelodisplastic Syndromes.
Phase:
Phase 2
Details
Lead Sponsor:
Fondazione Italiana Sindromi Mielodisplastiche Onlus Fondazione Italiana Sindromi Mielodisplastiche-ETS